MCL1 and nonpapillary renal cell carcinoma: We found that while the expression level of MCL-1 in ccRCC and chRCC tumors does not affect patients’ survival (Fig. 6AB), high expression of MCL-1 in pRCC tumors appears to be associated with worse patient survival (Fig. 6C).